GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EBR Systems Inc (OTCPK:EBRCZ) » Definitions » Debt-to-Revenue

EBRCZ (EBR Systems) Debt-to-Revenue : N/A (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is EBR Systems Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

EBR Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.55 Mil. EBR Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.29 Mil. EBR Systems's annualized Revenue for the quarter that ended in Jun. 2024 was $0.00 Mil.

EBR Systems Debt-to-Revenue Historical Data

The historical data trend for EBR Systems's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EBR Systems Debt-to-Revenue Chart

EBR Systems Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-Revenue
N/A N/A N/A

EBR Systems Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Revenue Get a 7-Day Free Trial N/A N/A N/A N/A N/A

Competitive Comparison of EBR Systems's Debt-to-Revenue

For the Medical Devices subindustry, EBR Systems's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EBR Systems's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EBR Systems's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where EBR Systems's Debt-to-Revenue falls into.


EBR Systems Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

EBR Systems's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.272 + 41.317) / N/A
=N/A

EBR Systems's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.548 + 0.294) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2024) Revenue data.

EBR Systems Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of EBR Systems's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

EBR Systems Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EBR Systems Inc (OTCPK:EBRCZ) » Definitions » Debt-to-Revenue
Comparable Companies
BFLY NPCE ZIMV AXGN XTNT OM TELA CLPT SMLR MASS ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
EBR:Australia
Address
480 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Website
https://www.ebrsystemsinc.com
EBR Systems Inc is engaged in treatment for patients suffering from cardiac rhythm diseases by developing therapies using wireless cardiac stimulation. The company's Wise CRT System uses proprietary wireless technology to deliver pacing stimulation directly inside of the left ventricle of the heart.